The group is subdivided according to mode of action.
The DDDs are based on prophylaxis.
M04AA - Preparations Inhibiting Uric Acid Production
Combinations of allupurinol and other antigout preparations are classified here. Rasburicase for the treatment of hyperuricemia is classified in V03AF.
